Browse > Article
http://dx.doi.org/10.14776/piv.2016.23.1.10

Comparison of Cervical-lymph-node-first Presentation of Kawasaki Disease and Typical Kawasaki Disease  

Yun, Hye-Won (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Lee, Jun-Yeol (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Yang, Song-I (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Yu, Hee-Joon (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Kang, Min-Jae (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Lee, So-Yeon (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Lee, Hae-Ran (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Kim, Kwang-Nam (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Kim, Sung-Hye (Department of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.23, no.1, 2016 , pp. 10-17 More about this Journal
Abstract
Purpose: The diagnosis of Kawasaki disease depends on clinical symptoms, which makes it difficult to diagnose early in patients with only cervical lymphadenopathy. The purpose of this study is to understand the clinical characteristics of cervical-lymph-node-first presentation of Kawasaki disease and compare them with those of typical Kawasaki disease. Methods: We surveyed 283 patients who were admitted to Hallym Sacred Heart Hospital and were diagnosed with Kawasaki disease from January 2012 to December 2014. The patients were divided into two groups: cervical-lymph-node-first presentation of Kawasaki disease (LKD, N=24) and typical Kawasaki disease (KD, N=259). The medical records were retrospectively reviewed. Results: The mean age of the LKD group was higher than that of the KD group (P=0.04). At admission, the LKD patients had on average 1.62 out of 5 symptoms, whereas the KD patients had 3.47. The time from fever to diagnosis and administration of IV immunoglobulin was longer in the LKD group than in the KD group (P<0.001). The mean C-reactive protein of the LKD group was higher than that of the KD group (P=0.01). There were no statistical differences in the presence of coronary artery complications between the two groups at two weeks or at two months after diagnosis (P=0.52, P=0.08). Conclusions: The Kawasaki disease patients with fever and cervical lymphadenopathy usually do not present obvious clinical symptoms, which makes it hard to diagnose in the early phase of disease. Clinician must pay attention when examining these patients.
Keywords
Kawasaki disease; Cervical lymph node; Children;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
2 Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States: 1976 to 1980. Am J Dis Child 1983;137:211-4.   DOI
3 Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991;118:680-6.   DOI
4 Mason WH, Takahashi M. Kawasaki syndrome. Clin Infect Dis 1999;28:169-85.   DOI
5 Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747-71.   DOI
6 Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7.   DOI
7 Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005;47:232-4.   DOI
8 Youn YS, Yoon HW, Kim SY, Sul JY, Song CJ, Kim JM, et al. Clinical evaluation of tissue biopsy for children with neck mass; a single center study. Korean J Pediatr 2005;48:839-45.
9 Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics 2005;115:e428-33.   DOI
10 Rowley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome. Rev Infect Dis 1988;10:1-15.   DOI
11 Kao HT, Huang YC, Lin TY. Kawasaki disease presenting as cervical lymphadenitis or deep neck infection. Otolaryngol Head Neck Surg 2001;124:468-70.   DOI
12 Stamos JK, Corydon K, Donaldson J, Shulman ST. Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994;93:525-8.
13 Kim JY, Kim JH, Moon SJ, Cho BS, Cha SH. Clinical characteristics of lymphadenopathy as the initial manifestation of Kawasaki disease. Korean J Pediatr Infect Dis 2000;7:152-8.   DOI
14 Tashiro N, Matsubara T, Uchida M, Katayama K, Ichiyama T, Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics 2002;109:e77.   DOI
15 Yanagi S, Nomura Y, Masuda K, Koriyama C, Sameshima K, Eguchi T, et al. Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy. Pediatr Int 2008;50:179-83.   DOI
16 Kubota M, Usami I, Yamakawa M, Tomita Y, Haruta T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatr Child Health 2008;44:359-62.   DOI
17 Kook DH, Ko YM, Lee KY, Kim DU, Lee KY, Lee JS. Characteristics of Kawasaki disease patients who are unresponsive to high-dose intravenous immunoglobulin therapy. Korean J Pediatr Infect Dis 2008;15:180-7.   DOI
18 Harada K. Intravenous ${\gamma}$-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10.   DOI
19 Zhang T, Yanagawa H, Oki I, Nakamura Y, Yashiro M, Ojima T, et al. Factors related to cardiac sequelae of Kawasaki disease. Eur J Pediatr 1999;158:694-7.   DOI
20 Nomura Y, Masuda K, Yoshinaga M, Sameshima K, Miyata K. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm. Pediatr Int 2002;44:353-7.   DOI
21 Muta H, Ishii M, Sakaue T, Egami K, Furui J, Sugahara Y, et al. Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease. Pediatrics 2004;114:751-4.   DOI
22 Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 1995;162:322-7.
23 Fan P, Chiu C, Yen M, Huang Y, Li C, Lin T. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement. J Paediatr Child Health 2003;39:55-7.   DOI
24 Lee KY, Hong JH, Han JW, Lee JS, Lee BC, Burgner D. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health 2006;42:423-7.   DOI
25 April MM, Burns JC, Newburger JW, Healy GB. Kawasaki disease and cervical adenopathy. Arch Otolaryngol Head Neck Surg 1989;115:512-4.   DOI
26 Nomura Y, Arata M, Koriyama C, Masuda K, Morita Y, Hazeki D, et al. A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission. J Pediatr 2010;156:786-91.   DOI